Jump Financial’s Janux Therapeutics JANX Stock Holding History

Jump Financial’s Portfolio JANX Stock Details JANX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.56M	Buy	361,665 +139,865	+63%	+$2.03M	0.04%	478
2026 Q1	$3.08M	Buy	221,800 +125,116	+129%	+$1.72M	0.04%	490
2025 Q4	$1.33M	Sell	96,684 -83,016	-46%	-$1.95M	0.02%	858
2025 Q3	$4.39M	Sell	179,700 -48,730	-21%	-$1.19M	0.05%	446
2025 Q2	$5.28M	Buy	228,430 +134,400	+143%	+$3.54M	0.06%	398
2025 Q1	$2.54M	Buy	+94,030	New	+$3.54M	0.03%	511
2024 Q3	–	Sell	-18,100	Closed	-$758K	–	1882
2024 Q2	$758K	Buy	18,100 +2,409	+15%	+$113K	0.02%	946
2024 Q1	$591K	Buy	+15,691	New	+$342K	0.02%	1082
2023 Q3	–	Sell	-10,821	Closed	-$128K	–	2050
2023 Q2	$128K	Buy	+10,821	New	+$145K	﹤0.01%	1614

Other funds holding JANX

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Jump Financial's JANX Position: Q2 2026 in Review

Jump Financial increased its Janux Therapeutics (JANX) stake by 63% in Q2 2026, buying an estimated $2.03M and bringing the position to 361,665 shares worth $5.56M. The position accounts for 0.04% of the portfolio, ranked #478.

Jump Financial first reported a position in JANX in Q2 2023 and has held it in 9 quarters since. 197 funds tracked by Wall St. Rank hold JANX as of Q2 2026.

Jump Financial held 361,665 shares of Janux Therapeutics worth $5.56M as of Q2 2026.
Jump Financial bought 139,865 Janux Therapeutics shares in Q2 2026, an estimated $2.03M.
Janux Therapeutics made up 0.04% of Jump Financial's portfolio in Q2 2026, its #478 holding.
Jump Financial first reported a position in Janux Therapeutics in Q2 2023 and has held it in 9 quarters since.
197 funds tracked by Wall St. Rank held Janux Therapeutics as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.